Cerner Co. (NASDAQ:CERN) VP Michael R. Battaglioli sold 4,000 shares of the stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $69.89, for a total transaction of $279,560.00. Following the sale, the vice president now directly owns 4,000 shares of the company’s stock, valued at approximately $279,560. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Cerner Co. (NASDAQ:CERN) traded up $0.85 during mid-day trading on Friday, reaching $69.42. 3,301,973 shares of the company’s stock were exchanged, compared to its average volume of 2,363,527. The firm has a market capitalization of $23,080.00, a PE ratio of 30.82, a P/E/G ratio of 2.25 and a beta of 0.94. The company has a current ratio of 2.77, a quick ratio of 2.75 and a debt-to-equity ratio of 0.11. Cerner Co. has a 12-month low of $47.09 and a 12-month high of $73.86.
Cerner (NASDAQ:CERN) last announced its quarterly earnings results on Thursday, October 26th. The company reported $0.61 EPS for the quarter, missing analysts’ consensus estimates of $0.62 by ($0.01). The firm had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.29 billion. Cerner had a net margin of 13.37% and a return on equity of 18.03%. The business’s revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.59 EPS. research analysts expect that Cerner Co. will post 2.25 EPS for the current fiscal year.
Several brokerages have recently issued reports on CERN. Jefferies Group set a $79.00 price objective on shares of Cerner and gave the stock a “buy” rating in a research report on Friday, October 13th. SunTrust Banks reaffirmed a “buy” rating and issued a $75.00 target price on shares of Cerner in a research report on Monday, October 30th. Royal Bank of Canada began coverage on shares of Cerner in a research report on Tuesday, September 19th. They issued a “top pick” rating and a $84.00 target price for the company. KeyCorp reaffirmed a “buy” rating and issued a $76.00 target price on shares of Cerner in a research report on Friday, September 22nd. Finally, Robert W. Baird raised shares of Cerner from a “neutral” rating to an “outperform” rating and raised their target price for the company from $67.00 to $76.00 in a research report on Tuesday, October 31st. One analyst has rated the stock with a sell rating, fourteen have given a hold rating and nine have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $69.50.
A number of hedge funds have recently made changes to their positions in CERN. Bank of New York Mellon Corp lifted its stake in Cerner by 19.0% in the second quarter. Bank of New York Mellon Corp now owns 17,546,618 shares of the company’s stock valued at $1,166,325,000 after acquiring an additional 2,800,955 shares during the last quarter. American Century Companies Inc. lifted its stake in Cerner by 62.4% in the second quarter. American Century Companies Inc. now owns 3,929,394 shares of the company’s stock valued at $261,187,000 after acquiring an additional 1,510,288 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Cerner by 3.1% during the 2nd quarter. Vanguard Group Inc. now owns 29,296,545 shares of the company’s stock worth $1,947,341,000 after buying an additional 876,919 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Cerner during the 2nd quarter worth about $44,524,000. Finally, Sawgrass Asset Management LLC acquired a new stake in shares of Cerner during the 3rd quarter worth about $39,946,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Cerner Co. (CERN) VP Michael R. Battaglioli Sells 4,000 Shares of Stock” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.dispatchtribunal.com/2017/12/16/cerner-co-cern-vp-michael-r-battaglioli-sells-4000-shares-of-stock.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.